The UT Southwestern Cancer Genetics Program, in partnership with the Division of Digestive and Liver Diseases, provides specialized care for patients with high-risk gastrointestinal malignancies.
Recently, Angelina Jolie informed the world through two New York Times opinion articles that she had her breasts and ovaries removed after learning she had a BRCA1 mutation.
The purpose of the tumor board is to provide a multidisciplinary review of somatic (tumor) testing for the purposes of clarifying the potential implications of a patient’s results.
The Cancer Genetics program works closely with pediatric oncologists at Children’s Health to provide cancer genetics services to pediatric patients in Dallas.
